The Immune Battle against Helicobacter pylori Infection: NO Offense

Trends in Microbiology

Volumn 24, Issue 5, 2016, Pages 366-376

  Gobert, Alain P ^a   Wilson, Keith T ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gastric cancer; Helicobacter pylori; Nitric oxide; Polyamines

Indexed keywords

ANTIBIOTIC AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; REACTIVE NITROGEN SPECIES;

BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BIOSYNTHESIS; CHRONIC GASTRITIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INDUCTION; EPITHELIUM CELL; GASTRIC MUCOSA; GENE EXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST CELL; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; NITROSATIVE STRESS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STOMACH; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; TRANSCRIPTION REGULATION; ANIMAL; CHRONIC DISEASE; GASTRITIS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; STOMACH MUCOSA; STOMACH TUMOR;

ANIMALS; CHRONIC DISEASE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; STOMACH NEOPLASMS;

EID: 84963575145     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2016.02.005     Document Type: Review

References (84)

1. Atherton J.C., Blaser M.J. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J. Clin. Invest. 2009, 119:2475-2487.
2. Umeda M., et al. Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability. J. Biol. Chem. 2009, 284:22166-22172.
3. Raju D., et al. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 2012, 142:1160-1171.
4. Noto J.M., et al. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J. Clin. Invest. 2013, 123:479-492.
5. Schneider B.G., et al. DNA methylation predicts progression of human gastric lesions. Cancer Epidemiol. Biomarkers Prev. 2015, 24:1607-1613.
6. Correa P., Piazuelo M.B. The gastric precancerous cascade. J. Dig. Dis. 2012, 13:2-9.
7. Fu S., et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999, 116:1319-1329.
8. Li C.Q., et al. Increased oxidative and nitrative stress in human stomach associated with cagA+ Helicobacter pylori infection and inflammation. Dig. Dis. Sci. 2001, 46:836-844.
9. Tatemichi M., et al. Enhanced expression of inducible nitric oxide synthase in chronic gastritis with intestinal metaplasia. J. Clin. Gastroenterol. 1998, 27:240-245.
10. Son H.J., et al. Inducible nitric oxide synthase expression in gastroduodenal diseases infected with Helicobacter pylori. Helicobacter 2001, 6:37-43.
11. Antos D., et al. Inducible nitric oxide synthase expression before and after eradication of Helicobacter pylori in different forms of gastritis. FEMS Immunol. Med. Microbiol. 2001, 30:127-131.
12. Goto T., et al. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin. Cancer Res. 1999, 5:1411-1415.
13. Mannick E.E., et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 1996, 56:3238-3243.
14. Hahm K.B., et al. Possibility of chemoprevention by the eradication of Helicobacter pylori: oxidative DNA damage and apoptosis in H. pylori infection. Am. J. Gastroenterol. 1997, 92:1853-1857.
15. Felley C.P., et al. Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication. Helicobacter 2002, 7:342-348.
16. Sakaguchi A.A., et al. Increased expression of inducible nitric oxide synthase and peroxynitrite in Helicobacter pylori gastric ulcer. Free Radic. Biol. Med. 1999, 27:781-789.
17. Chaturvedi R., et al. Polyamines impair immunity to Helicobacter pylori by inhibiting L-arginine uptake required for nitric oxide production. Gastroenterology 2010, 139:1686-1698.
18. Lewis N.D., et al. Immune evasion by Helicobacter pylori is mediated by induction of macrophage arginase II. J. Immunol. 2011, 186:3632-3641.
19. Touati E., et al. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 2003, 124:1408-1419.
20. Matsubara S., et al. Cloning of Mongolian gerbil cDNAs encoding inflammatory proteins, and their expression in glandular stomach during H. pylori infection. Cancer Sci. 2004, 95:798-802.
21. Elfvin A., et al. Gastric expression of inducible nitric oxide synthase and myeloperoxidase in relation to nitrotyrosine in Helicobacter pylori-infected Mongolian gerbils. Scand. J. Gastroenterol. 2006, 41:1013-1018.
22. Lee C.W., et al. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 2008, 68:3540-3548.
23. Barry D.P., et al. Cationic amino acid transporter 2 enhances innate immunity during Helicobacter pylori infection. PLoS ONE 2011, 6:e29046.
24. Perez-Perez G.I., et al. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect. Immun. 1995, 63:1183-1187.
25. Assmann I.A., et al. Role of virulence factors, cell components and adhesion in Helicobacter pylori-mediated iNOS induction in murine macrophages. FEMS Immunol. Med. Microbiol. 2001, 30:133-138.
26. Kim J.M., et al. Up-regulation of inducible nitric oxide synthase and nitric oxide in Helicobacter pylori-infected human gastric epithelial cells: possible role of interferon-gamma in polarized nitric oxide secretion. Helicobacter 2002, 7:116-128.
27. Cho S.O., et al. Involvement of Ras and AP-1 in Helicobacter pylori-induced expression of COX-2 and iNOS in gastric epithelial AGS cells. Dig. Dis. Sci. 2010, 55:988-996.
28. Angrisano T., et al. Helicobacter pylori regulates iNOS promoter by histone modifications in human gastric epithelial cells. Med. Microbiol. Immunol. 2012, 201:249-257.
29. Perfetto B., et al. Interferon-gamma cooperates with Helicobacter pylori to induce iNOS-related apoptosis in AGS gastric adenocarcinoma cells. Res. Microbiol. 2004, 155:259-266.
30. Kim J.M., et al. Helicobacter pylori infection activates NF-kappaB signaling pathway to induce iNOS and protect human gastric epithelial cells from apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G1171-G1180.
31. Uno K., et al. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G1004-G1012.
32. Wilson K.T., et al. Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology 1996, 111:1524-1533.
33. Matsuyama N., et al. Non-standard biological activities of lipopolysaccharide from Helicobacter pylori. J. Med. Microbiol. 2001, 50:865-869.
34. Xie Q.W., et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256:225-228.
35. Gobert A.P., et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13844-13849.
36. Gobert A.P., et al. Cutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J. Immunol. 2002, 168:6002-6006.
37. Schwartz J.T., Allen L.A. Role of urease in megasome formation and Helicobacter pylori survival in macrophages. J. Leukoc. Biol. 2006, 79:1214-1225.
38. Miyazawa M., et al. Suppressed apoptosis in the inflamed gastric mucosa of Helicobacter pylori-colonized iNOS-knockout mice. Free Radic. Biol. Med. 2003, 34:1621-1630.
39. Obonyo M., et al. Interactions between inducible nitric oxide and other inflammatory mediators during Helicobacter pylori infection. Helicobacter 2003, 8:495-502.
40. Hirahashi M., et al. Induced nitric oxide synthetase and peroxiredoxin expression in intramucosal poorly differentiated gastric cancer of young patients. Pathol. Int. 2014, 64:155-163.
41. Nam K.T., et al. Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase. Gut 2004, 53:1250-1255.
42. Tatemichi M., et al. Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter. Cancer Lett. 2005, 217:197-202.
43. Kaise M., et al. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma. Eur. J. Gastroenterol. Hepatol. 2007, 19:139-145.
44. Ma N., et al. Accumulation of 8-nitroguanine in human gastric epithelium induced by Helicobacter pylori infection. Biochem. Biophys. Res. Commun. 2004, 319:506-510.
45. Katsurahara M., et al. Reactive nitrogen species mediate DNA damage in Helicobacter pylori-infected gastric mucosa. Helicobacter 2009, 14:552-558.
46. Yermilov V., et al. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis 1995, 16:2045-2050.
47. Tsuji S., et al. Helicobacter pylori and gastric carcinogenesis. J. Clin. Gastroenterol. 1997, 25(Suppl. 1):S186-S197.
48. Watanabe S., et al. Helicobacter pylori induces apoptosis in gastric epithelial cells through inducible nitric oxide. J. Gastroenterol. Hepatol. 2000, 15:168-174.
49. Gobert A.P., et al. Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J. Immunol. 2002, 168:4692-4700.
50. Chaturvedi R., et al. Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J. Biol. Chem. 2004, 279:40161-40173.
51. Vareille M., et al. Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:10199-10204.
52. Branchu P., et al. NsrR, GadE, and GadX interplay in repressing expression of the Escherichia coli O157:H7 LEE pathogenicity island in response to nitric oxide. PLoS Pathog. 2014, 10:e1003874.
53. D'Autreaux B., et al. A non-haem iron centre in the transcription factor NorR senses nitric oxide. Nature 2005, 437:769-772.
54. Gilberthorpe N.J., Poole R.K. Nitric oxide homeostasis in Salmonella typhimurium: roles of respiratory nitrate reductase and flavohemoglobin. J. Biol. Chem. 2008, 283:11146-11154.
55. Bang I.S., et al. Maintenance of nitric oxide and redox homeostasis by the Salmonella flavohemoglobin hmp. J. Biol. Chem. 2006, 281:28039-28047.
56. Hung C.L., et al. The CrdRS two-component system in Helicobacter pylori responds to nitrosative stress. Mol. Microbiol. 2015, 97:1128-1141.
57. Kuwahara H., et al. Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production. Infect. Immun. 2000, 68:4378-4383.
58. Lewis N.D., et al. Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages. J. Immunol. 2010, 184:2572-2582.
59. Moyat M., et al. Role of inflammatory monocytes in vaccine-induced reduction of Helicobacter felis infection. Infect. Immun. 2015, 83:4217-4228.
60. Nagata K., et al. Helicobacter pylori generates superoxide radicals and modulates nitric oxide metabolism. J. Biol. Chem. 1998, 273:14071-14073.
61. Qu W., et al. Identification of S-nitrosylation of proteins of Helicobacter pylori in response to nitric oxide stress. J. Microbiol. 2011, 49:251-256.
62. Bodenmiller D.M., Spiro S. The yjeB (nsrR) gene of Escherichia coli encodes a nitric oxide-sensitive transcriptional regulator. J. Bacteriol. 2006, 188:874-881.
63. Poole R.K., et al. Nitric oxide, nitrite, and Fnr regulation of hmp (flavohemoglobin) gene expression in Escherichia coli K-12. J. Bacteriol. 1996, 178:5487-5492.
64. Justino M.C., et al. Helicobacter pylori has an unprecedented nitric oxide detoxifying system. Antioxid. Redox Signal. 2012, 17:1190-1200.
65. Justino M.C., et al. FrxA is an S-nitrosoglutathione reductase enzyme that contributes to Helicobacter pylori pathogenicity. FEBS J. 2014, 281:4495-4505.
66. Kuhns L.G., et al. Comparative roles of the two Helicobacter pylori thioredoxins in preventing macromolecule damage. Infect. Immun. 2015, 83:2935-2943.
67. Comtois S.L., et al. Role of the thioredoxin system and the thiol-peroxidases Tpx and Bcp in mediating resistance to oxidative and nitrosative stress in Helicobacter pylori. Microbiology 2003, 149:121-129.
68. McGee D.J., et al. Helicobacter pylori thioredoxin is an arginase chaperone and guardian against oxidative and nitrosative stresses. J. Biol. Chem. 2006, 281:3290-3296.
69. Qu W., et al. Helicobacter pylori proteins response to nitric oxide stress. J. Microbiol. 2009, 47:486-493.
70. Bryk R., et al. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 2000, 407:211-215.
71. Lu J., Holmgren A. The thioredoxin antioxidant system. Free Radic. Biol. Med. 2014, 66:75-87.
72. Gobert A.P., et al. Heme oxygenase-1 dysregulates macrophage polarization and the immune response to Helicobacter pylori. J. Immunol. 2014, 193:3013-3022.
73. Fandriks L., et al. Water extract of Helicobacter pylori inhibits duodenal mucosal alkaline secretion in anesthetized rats. Gastroenterology 1997, 113:1570-1575.
74. von Bothmer C., et al. Helicobacter pylori infection inhibits antral mucosal nitric oxide production in humans. Scand. J. Gastroenterol. 2002, 37:404-408.
75. Aydemir S., et al. Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels. Mediators Inflamm. 2010, 2010:685903.
76. Bussiere F.I., et al. Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J. Biol. Chem. 2005, 280:2409-2412.
77. Chaturvedi R., et al. L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect. Immun. 2007, 75:4305-4315.
78. Barry D.P., et al. Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. PLoS ONE 2011, 6:e17510.
79. McGee D.J., et al. Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity. J. Bacteriol. 1999, 181:7314-7322.
80. Falush D., et al. Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:15056-15061.
81. Cunningham M.D., et al. Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14. Infect. Immun. 1996, 64:3601-3608.
82. Mueller D., et al. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J. Clin. Invest. 2012, 122:1553-1566.
83. Higashi H., et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002, 295:683-686.
84. Supajatura V., et al. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J. Immunol. 2002, 168:2603-2607.